MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328AA8. A total of 16 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,138,000 | +29.3% | 1,331,000 | 0.0% | 0.04% | +24.2% |
| Q2 2017 | $880,000 | -21.8% | 1,331,000 | 0.0% | 0.03% | -23.3% |
| Q1 2017 | $1,125,000 | -11.4% | 1,331,000 | 0.0% | 0.04% | -10.4% |
| Q4 2016 | $1,270,000 | -23.9% | 1,331,000 | -0.4% | 0.05% | -18.6% |
| Q3 2016 | $1,668,000 | +3.8% | 1,336,000 | -5.3% | 0.06% | +1.7% |
| Q2 2016 | $1,607,000 | -26.0% | 1,411,000 | 0.0% | 0.06% | -18.3% |
| Q1 2016 | $2,172,000 | +9.5% | 1,411,000 | +5.5% | 0.07% | +10.9% |
| Q4 2015 | $1,984,000 | -10.1% | 1,337,000 | -5.2% | 0.06% | -1.5% |
| Q3 2015 | $2,206,000 | -13.2% | 1,410,000 | +16.5% | 0.06% | 0.0% |
| Q2 2015 | $2,542,000 | -1.2% | 1,210,000 | -5.7% | 0.06% | 0.0% |
| Q1 2015 | $2,572,000 | +5.7% | 1,283,000 | 0.0% | 0.06% | +10.2% |
| Q4 2014 | $2,434,000 | +22.0% | 1,283,000 | 0.0% | 0.06% | +15.7% |
| Q3 2014 | $1,995,000 | +15.2% | 1,283,000 | 0.0% | 0.05% | +21.4% |
| Q2 2014 | $1,732,000 | +32.6% | 1,283,000 | +0.3% | 0.04% | +31.2% |
| Q1 2014 | $1,306,000 | -7.3% | 1,279,000 | -5.5% | 0.03% | -13.5% |
| Q4 2013 | $1,409,000 | -56.1% | 1,353,000 | -61.7% | 0.04% | -57.5% |
| Q3 2013 | $3,209,000 | – | 3,529,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|